pravastatin has been researched along with Tachycardia, Ventricular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albano, A; Aronovitz, M; Galper, JB; Jin, H; Link, MS; Noujaim, SF; Park, HJ; Rajab, M; Welzig, CM; Zhang, Y | 1 |
Ezaki, K; Fukui, A; Hara, M; Kume, O; Miyazaki, H; Nakagawa, M; Nishio, S; Saikawa, T; Takahashi, N; Teshima, Y; Thuc, LC; Yufu, K | 1 |
Chang, NC; Lee, TM; Lin, MS | 1 |
3 other study(ies) available for pravastatin and Tachycardia, Ventricular
Article | Year |
---|---|
Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatin.
Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Pravastatin; Tachycardia, Ventricular | 2013 |
Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart.
Topics: Administration, Oral; Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Coronary Vessels; Heart Ventricles; Ligation; Male; Membrane Potential, Mitochondrial; Models, Animal; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pravastatin; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2011 |
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GAP-43 Protein; Glyburide; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; KATP Channels; Ligation; Male; Myocardial Infarction; Myocardium; Neurofilament Proteins; Nicorandil; Norepinephrine; Pinacidil; Polymerase Chain Reaction; Potassium Channel Blockers; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors; Tyrosine 3-Monooxygenase; Ventricular Fibrillation; Ventricular Remodeling | 2007 |